-
761
-
762
A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells
Published 2025-01-01Subjects: Get full text
Article -
763
Innovative CDR grafting and computational methods for PD-1 specific nanobody design
Published 2025-01-01Subjects: “…cancer immunotherapy…”
Get full text
Article -
764
Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome
Published 2025-02-01Subjects: Get full text
Article -
765
Pollen–Food Allergy Syndrome: Allergens, Clinical Insights, Diagnostic and Therapeutic Challenges
Published 2024-12-01Subjects: Get full text
Article -
766
-
767
-
768
Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses
Published 2025-01-01Subjects: Get full text
Article -
769
Inhibition of anti-tumour reactivity of immune cells in the salivary gland cancer: A proteomic approach
Published 2024-03-01Subjects: Get full text
Article -
770
STAMBPL1/TRIM21 Balances AXL Stability Impacting Mesenchymal Phenotype and Immune Response in KIRC
Published 2025-01-01Subjects: “…immunotherapy resistance…”
Get full text
Article -
771
Lutetium-177 labeled iPD-L1 as a novel immunomodulator for cancer-targeted radiotherapy
Published 2025-01-01Subjects: Get full text
Article -
772
It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
Published 2025-01-01Subjects: Get full text
Article -
773
Reshaping Resistance: How Autovaccine Therapy Alters the Course of Recurrent Multidrug-Resistant Urinary Tract Infections
Published 2025-01-01Subjects: Get full text
Article -
774
Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia
Published 2025-01-01Subjects: “…chimeric antigen receptor immunotherapy…”
Get full text
Article -
775
-
776
Advances in adjuvant therapy for operable N2 non-small cell lung cancer: a narrative review
Published 2025-01-01Subjects: Get full text
Article -
777
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
Published 2025-02-01Subjects: Get full text
Article -
778
-
779
-
780
Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
Published 2025-01-01Subjects: Get full text
Article